Gynecological radiotherapy

Publications from OUS - Section for gynaecological radiotherapy

30 publications found

Publications 2022

  1. Lindegaard JC, Petric P, Schmid MP, Nesvacil N, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Kirchheiner K, Spampinato S, Jürgenliemk-Schulz I, Tanderup K, Kirisits C et al. (2022)
    Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study
    Int J Radiat Oncol Biol Phys, 113 (2), 379-389
    DOI 10.1016/j.ijrobp.2022.02.005, PubMed 35157992
  2. Skipar K, Hompland T, Lund KV, Løndalen A, Malinen E, Kristensen GB, Lindemann K, Nakken ES, Bruheim K, Lyng H (2022)
    Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET/CT in locally advanced cervical cancer
    Radiother Oncol, 176, 17-24 (in press)
    DOI 10.1016/j.radonc.2022.09.002, PubMed 36113778
  3. Westerveld H, Kirchheiner K, Nout RA, Tanderup K, Lindegaard JC, Spampinato S, Sturdza A, Nesvacil N, Bruheim K, Hellebust TP, Pieters BR, Kirisits C, Jürgenliemk-Schulz IM, Pötter R, de Leeuw AAC (2022)
    Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study
    Radiother Oncol, 168, 8-15
    DOI 10.1016/j.radonc.2021.12.034, PubMed 35063582

Publications 2021

  1. Areklett EW, Fagereng E, Bruheim K, Andersson S, Lindemann K (2021)
    Self-reported cognitive impairment in cervical cancer survivors: A cross-sectional study
    Psychooncology, 31 (2), 298-305
    DOI 10.1002/pon.5818, PubMed 34516040
  2. Kirchheiner K, Smet S, Jürgenliemk-Schulz IM, Haie-Meder C, Chargari C, Lindegaard JC, Fokdal LU, Spampinato S, Schmid MP, Sturdza A, Mahantshetty U, Segedin B, Bruheim K, Rai B, Cooper R, Van der Steen-Banasik E, Wiebe E, Sundset M, van Limbergen E, Villafranca E, Westerveld H, Tan LT, Pötter R, Tanderup K, Nout RA et al. (2021)
    Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study
    Int J Radiat Oncol Biol Phys, 112 (2), 400-413
    DOI 10.1016/j.ijrobp.2021.08.036, PubMed 34478833
  3. Lindemann K, Smogeli E, Småstuen MC, Bruheim K, Trovik J, Nordberg T, Kristensen GB, Werner HMJ, Nakken E (2021)
    Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer
    Cancers (Basel), 13 (6)
    DOI 10.3390/cancers13061367, PubMed 33803531
  4. Peters M, de Leeuw AAC, Nomden CN, Tanderup K, Kirchheiner K, Lindegaard JC, Kirisits C, Haie-Meder C, Sturdza A, Fokdal L, Mahantshetty U, Hoskin P, Segedin B, Bruheim K, Rai B, Huang F, Cooper R, van der Steen-Banasik E, van Limbergen E, Pieters BR, Tan LT, van Rossum PSN, Nesvacil N, Nout R, Schmid MP et al. (2021)
    Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis
    Radiother Oncol, 163, 150-158
    DOI 10.1016/j.radonc.2021.08.020, PubMed 34480958
  5. Pötter R, Tanderup K, Schmid MP, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Ristl R, Petric P, Nesvacil N, Kirchheiner K, Kirisits C et al. (2021)
    MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
    Lancet Oncol, 22 (4), 538-547
    DOI 10.1016/S1470-2045(20)30753-1, PubMed 33794207
  6. Seland M, Skrede K, Lindemann K, Skaali T, Blomhoff R, Bruheim K, Wisløff T, Thorsen L (2021)
    Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer
    Acta Obstet Gynecol Scand, 101 (3), 313-322
    DOI 10.1111/aogs.14310, PubMed 34964982
  7. Smet S, Spampinato S, Pötter R, Jürgenliemk-Schulz IM, Nout RA, Chargari C, Mahantshetty U, Sturdza A, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, Van der Steen-Banasik E, Sundset M, Van Limbergen E, Tan LT, Lutgens LCHW, Villafranca E, Pieters BR, Tanderup K, Kirchheiner K (2021)
    Risk Factors for Late Persistent Fatigue After Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: An Analysis From the EMBRACE-I Study
    Int J Radiat Oncol Biol Phys, 112 (5), 1177-1189
    DOI 10.1016/j.ijrobp.2021.11.022, PubMed 34838868
  8. Spampinato S, Fokdal LU, Pötter R, Haie-Meder C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van der Steen-Banasik E, Van Limbergen E, Sundset M, Westerveld H, Nout RA, Jensen NBK, Kirisits C, Kirchheiner K, Tanderup K, EMBRACE Collaborative Group (2021)
    Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis
    Radiother Oncol, 158, 312-320
    DOI 10.1016/j.radonc.2021.01.019, PubMed 33545254
  9. Spampinato S, Fokdal LU, Pötter R, Haie-Meder C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van der Steen-Banasik E, Van Limbergen E, Sundset M, Westerveld H, Nout RA, Jensen NBK, Kirisits C, Kirchheiner K, Tanderup K, EMBRACE Collaborative Group (2021)
    Response to Yuce Sari et al
    Radiother Oncol, 158, 323-324
    DOI 10.1016/j.radonc.2021.02.022, PubMed 33647355
  10. Spampinato S, Jensen NBK, Pötter R, Fokdal LU, Chargari C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Hoskin P, Segedin B, Rai B, Bruheim K, Wiebe E, Van der Steen-Banasik E, Cooper R, Van Limbergen E, Sundset M, Pieters BR, Lutgens LCHW, Tan LT, Villafranca E, Smet S, Jastaniyah N et al. (2021)
    Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future
    Int J Radiat Oncol Biol Phys, 112 (3), 681-693
    DOI 10.1016/j.ijrobp.2021.09.055, PubMed 34678431

Publications 2020

  1. Bell L, Holloway L, Bruheim K, Petrič P, Kirisits C, Tanderup K, Pötter R, Vinod S, Lim K, Pogson E, Metcalfe P, Hellebust TP (2020)
    Dose planning variations related to delineation variations in MRI-guided brachytherapy for locally advanced cervical cancer
    Brachytherapy, 19 (2), 146-153
    DOI 10.1016/j.brachy.2020.01.002, PubMed 32067884
  2. K Jensen NB, Pötter R, Spampinato S, Fokdal LU, Chargari C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Wiebe E, Cooper R, Van der Steen-Banasik E, Van Limbergen E, Sundset M, Pieters BR, Nout RA, Kirisits C, Kirchheiner K, Tanderup K, EMBRACE Collaborative Group (2020)
    Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study
    Int J Radiat Oncol Biol Phys, 109 (3), 688-700
    DOI 10.1016/j.ijrobp.2020.10.006, PubMed 33068689
  3. Knoth J, Pötter R, Jürgenliemk-Schulz IM, Haie-Meder C, Fokdal L, Sturdza A, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Wiebe E, Rai B, Cooper R, van der Steen-Banasik E, van Limbergen E, Pieters BR, Sundset M, Tan LT, Nout RA, Tanderup K, Kirisits C, Nesvacil N, Lindegaard JC, Schmid MP (2020)
    Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study
    Gynecol Oncol, 159 (1), 136-141
    DOI 10.1016/j.ygyno.2020.07.007, PubMed 32798000
  4. Spampinato S, Fokdal LU, Pötter R, Haie-Meder C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van der Steen-Banasik E, Van Limbergen E, Sundset M, Westerveld H, Nout RA, Jensen NBK, Kirisits C, Kirchheiner K, Tanderup K, EMBRACE Collaborative Group (2020)
    Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis
    Radiother Oncol, 158, 300-308
    DOI 10.1016/j.radonc.2020.10.003, PubMed 33065183
  5. Vittrup AS, Tanderup K, Bentzen SM, Jensen NBK, Spampinato S, Fokdal LU, Lindegaard JC, Sturdza A, Schmid M, Segedin B, Jürgenliemk-Schulz IM, Bruheim K, Mahantshetty U, Haie-Meder C, Rai B, Cooper R, van der Steen-Banasik E, Sundset M, Huang F, Nout RA, Villafranca E, Van Limbergen E, Pieters BR, Tan LT, Lutgens LCHW et al. (2020)
    Persistence of Late Substantial Patient-Reported Symptoms (LAPERS) After Radiochemotherapy Including Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: A Report From the EMBRACE Study
    Int J Radiat Oncol Biol Phys, 109 (1), 161-173
    DOI 10.1016/j.ijrobp.2020.08.044, PubMed 32853710

Publications 2019

  1. Nomden CN, Pötter R, de Leeuw AAC, Tanderup K, Lindegaard JC, Schmid MP, Fortin I, Haie-Meder C, Mahantshetty U, Hoskin P, Segedin B, Bruheim K, Rai B, Huang F, Cooper R, Van Der Steen Banasik E, Van Limbergen E, Jürgenliemk-Schulz IM, EMBRACE Collaborative Group (2019)
    Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort
    Radiother Oncol, 134, 185-190
    DOI 10.1016/j.radonc.2019.02.007, PubMed 31005214

Publications 2018

  1. Fokdal L, Tanderup K, Pötter R, Sturdza A, Kirchheiner K, Chargari C, Jürgenliemk-Schulz IM, Segedin B, Tan LT, Hoskin P, Mahantshetty U, Bruheim K, Rai B, Kirisits C, Lindegaard JC, EMBRACE Collaborative Group (2018)
    Risk Factors for Ureteral Stricture After Radiochemotherapy Including Image Guided Adaptive Brachytherapy in Cervical Cancer: Results From the EMBRACE Studies
    Int J Radiat Oncol Biol Phys, 103 (4), 887-894
    DOI 10.1016/j.ijrobp.2018.11.006, PubMed 30419309
  2. Najjari Jamal D, Pötter R, Haie-Meder C, Lindegaard JC, Juergenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Wiebe E, Cooper R, Tanderup K, Kirchheiner K, EMBRACE collaborative group (2018)
    Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study
    Radiother Oncol, 127 (3), 449-455
    DOI 10.1016/j.radonc.2018.03.026, PubMed 29631933
  3. Pötter R, Tanderup K, Kirisits C, de Leeuw A, Kirchheiner K, Nout R, Tan LT, Haie-Meder C, Mahantshetty U, Segedin B, Hoskin P, Bruheim K, Rai B, Huang F, Van Limbergen E, Schmid M, Nesvacil N, Sturdza A, Fokdal L, Jensen NBK, Georg D, Assenholt M, Seppenwoolde Y, Nomden C, Fortin I et al. (2018)
    The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
    Clin Transl Radiat Oncol, 9, 48-60
    DOI 10.1016/j.ctro.2018.01.001, PubMed 29594251
  4. Smet S, Pötter R, Haie-Meder C, Lindegaard JC, Schulz-Juergenliemk I, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van Limbergen E, Tanderup K, Kirchheiner K, EMBRACE Collaborative Group (2018)
    Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study
    Radiother Oncol, 127 (3), 440-448
    DOI 10.1016/j.radonc.2018.03.009, PubMed 29627137

Publications 2016

  1. Arnesen MR, Rekstad BL, Stokke C, Bruheim K, Løndalen AM, Hellebust TP, Malinen E (2016)
    Short-course PET based simultaneous integrated boost for locally advanced cervical cancer
    Radiat Oncol, 11, 39
    DOI 10.1186/s13014-016-0612-z, PubMed 26968827

Publications 2015

  1. Arnesen MR, Knudtsen IS, Rekstad BL, Eilertsen K, Dale E, Bruheim K, Helland Å, Løndalen AM, Hellebust TP, Malinen E (2015)
    Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps
    Acta Oncol, 54 (9), 1607-13
    DOI 10.3109/0284186X.2015.1061690, PubMed 26213311

Publications 2014

  1. Arnesen MR, Bruheim K, Malinen E, Hellebust TP (2014)
    Spatial dosimetric sensitivity of contouring uncertainties in gynecological 3D-based brachytherapy
    Radiother Oncol, 113 (3), 414-9
    DOI 10.1016/j.radonc.2014.11.016, PubMed 25434766

Publications 2010

  1. Brændengen M, Tveit KM, Bruheim K, Cvancarova M, Berglund Å, Glimelius B (2010)
    Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study
    Int J Radiat Oncol Biol Phys, 81 (4), 1017-24
    DOI 10.1016/j.ijrobp.2010.07.007, PubMed 20932687

Publications 2009

  1. Bruheim K, Guren MG, Dahl AA, Skovlund E, Balteskard L, Carlsen E, Fosså SD, Tveit KM (2009)
    Sexual function in males after radiotherapy for rectal cancer
    Int J Radiat Oncol Biol Phys, 76 (4), 1012-7
    DOI 10.1016/j.ijrobp.2009.03.075, PubMed 19880263
  2. Bruheim K, Guren MG, Skovlund E, Hjermstad MJ, Dahl O, Frykholm G, Carlsen E, Tveit KM (2009)
    Late side effects and quality of life after radiotherapy for rectal cancer
    Int J Radiat Oncol Biol Phys, 76 (4), 1005-11
    DOI 10.1016/j.ijrobp.2009.03.010, PubMed 19540058

Publications 2008

  1. Bruheim K, Svartberg J, Carlsen E, Dueland S, Haug E, Skovlund E, Tveit KM, Guren MG (2008)
    Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH
    Int J Radiat Oncol Biol Phys, 70 (3), 722-7
    DOI 10.1016/j.ijrobp.2007.10.043, PubMed 18262088

 
Page visits: 976